FibroGen (FGEN) Tops Q4 EPS by 35c
Tweet
Share
E-mail
Get Alerts FGEN Hot Sheet
Join SI Premium – FREE
FibroGen (NASDAQ: FGEN) reported Q4 EPS of $0.18, $0.35 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $3.1 million versus the consensus estimate of $22.09 million.
For earnings history and earnings-related data on FibroGen (FGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apple suing OpenAI over alleged misappropriation of trade secrets
- Faraday Future registers up to 62M shares for resale
- Men’s Wearhouse owner Tailored Brands, bankrupt in 2020, files for IPO
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
